Filings

6 documents · 47 matches

1. SPRO Spero Therapeutics, Inc. 10-Q 2026-05-13

   Item 1A. Risk Factors.

   tariffs and the fentanyl tariffs were imposed pursuant to the International Emergency Economic Powers Act (the “IEEPA”). These tariffs were
   11 matches in this document Show context Copy citation

2. SPRO Spero Therapeutics, Inc. 10-Q 2026-08-12

   Item 1A. Risk Factors.

   tariff-related actions against U.S. trading partners. On April 2, 2025, an executive order announced a “baseline” reciprocal tariff of 10% on all U.S. trading
   11 matches in this document Show context Copy citation

3. SPRO Spero Therapeutics, Inc. 10-K 2026-03-26

   Item 1A. Risk Factors.

   tariff-related actions against U.S. trading partners. On April 2, 2025, an executive order announced a “baseline” reciprocal tariff of 10% on all U.S. trading
   10 matches in this document Show context Copy citation

4. SPRO Spero Therapeutics, Inc. 10-Q 2025-11-13

   Item 1A. Risk Factors.

   tariff of 10% on all U.S. trading partners effective April 5, 2025, and higher individualized reciprocal tariffs on 57 countries
   6 matches in this document Show context Copy citation

5. SPRO Spero Therapeutics, Inc. 10-Q 2025-08-12

   Item 1A. Risk Factors.

   tariff of 10% on all U.S. trading partners effective April 5, 2025, and higher individualized reciprocal tariffs on 57 countries
   7 matches in this document Show context Copy citation

6. SPRO Spero Therapeutics, Inc. 10-Q 2025-05-13

   Item 1A. Risk Factors.

   unexpected changes in tariffs, trade barriers and regulatory requirements;
   2 matches in this document Show context Copy citation